Healthcare provider profile · identity verified

Michael Jay Reeves, MD

Family Practice · GREENFIELD, MA · NPI 1467518308

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	339	98
Lisinopril	Lisinopril	285	87
Amlodipine Besylate	Amlodipine Besylate	268	78
Gabapentin	Gabapentin	241	49
Simvastatin	Simvastatin	206	46
Levothyroxine Sodium	Levothyroxine Sodium	188	43
Tamsulosin Hcl	Tamsulosin Hcl	162	48
Omeprazole	Omeprazole	158	52
Metoprolol Succinate	Metoprolol Succinate	143	44
Losartan Potassium	Losartan Potassium	136	39
Trazodone Hcl	Trazodone Hcl	118	22
Eliquis	Apixaban	117	30
Albuterol Sulfate Hfa	Albuterol Sulfate	115	46
Hydrochlorothiazide	Hydrochlorothiazide	115	36
Allopurinol	Allopurinol	108	30
Pantoprazole Sodium	Pantoprazole Sodium	104	32
Metformin Hcl Er	Metformin Hcl	103	27
Finasteride	Finasteride	102	29
Metformin Hcl	Metformin Hcl	99	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	26
Prednisone	Prednisone	92	54
Famotidine	Famotidine	90	21
Rosuvastatin Calcium	Rosuvastatin Calcium	76	24
Fluticasone Propionate	Fluticasone Propionate	68	28
Meloxicam	Meloxicam	66	26
Clopidogrel	Clopidogrel Bisulfate	65	20
Tizanidine Hcl	Tizanidine Hcl	63	12
Tramadol Hcl	Tramadol Hcl	60	28
Oxycodone Hcl	Oxycodone Hcl	59	suppressed
Montelukast Sodium	Montelukast Sodium	55	13
Furosemide	Furosemide	53	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	suppressed
Ozempic	Semaglutide	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	14
Venlafaxine Hcl Er	Venlafaxine Hcl	48	11
Atenolol	Atenolol	45	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	44	suppressed
Bupropion Xl	Bupropion Hcl	43	11
Pravastatin Sodium	Pravastatin Sodium	43	13
Celecoxib	Celecoxib	41	13
Breo Ellipta	Fluticasone/Vilanterol	40	13
Ventolin Hfa	Albuterol Sulfate	40	13
Metoprolol Tartrate	Metoprolol Tartrate	39	13
Lorazepam	Lorazepam	38	18
Sertraline Hcl	Sertraline Hcl	38	suppressed
Spironolactone	Spironolactone	38	12
Trulicity	Dulaglutide	38	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Carvedilol	Carvedilol	35	13
Clonidine Hcl	Clonidine Hcl	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	31
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Baclofen	Baclofen	30	15
Valacyclovir	Valacyclovir Hcl	29	13
Myrbetriq	Mirabegron	28	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Mupirocin	Mupirocin	25	24
Valsartan	Valsartan	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Lidocaine	Lidocaine	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Diazepam	Diazepam	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Nystatin	Nystatin	15	11
Ondansetron Odt	Ondansetron	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Glipizide	Glipizide	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Estradiol	Estradiol	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error